EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

The effect of thyroid hormone therapy on muscle function, strength and mass in older adults with subclinical hypothyroidism—an ancillary study within two randomized placebo controlled trials

Seraina Netzer iD, Patricia Chocano-Bedoya, Martin Feller, Camilla Janett-Pellegri, Lea Wildisen, Annina E Büchi, Elisavet Moutzouri, Elena Gonzalez Rodriguez iD, Tinh-Hai Collet, Rosalinde K E Poortvliet, Vera J C Mc Carthy, Daniel Aeberli und 8 weitere

Age and Ageing · 08.01.2023 · 52 (1)

DOI: 10.1093/ageing/afac326 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Age and Ageing, online erschienen am 27.01.2023. Verfasst von Seraina Netzer und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Hypothyroidism, Thyroid Hormones. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Swiss National Science Foundation, ZonMw programme Evidence-based Medicine in Old age.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background loss of skeletal muscle function, strength and mass is common in older adults, with important socioeconomic impacts. Subclinical hypothyroidism is common with increasing age and has been associated with reduced muscle strength. Yet, no randomized placebo-controlled trial (RCT) has investigated whether treatment of subclinical hypothyroidism affects muscle function and mass. Methods this is an ancillary study within two RCTs conducted among adults aged ≥65 years with persistent subclinical hypothyroidism (thyrotropin (TSH) 4.60–19.99 mIU/l, normal free thyroxine). Participants received daily levothyroxine with TSH-guided dose adjustment or placebo and mock titration. Primary outcome was gait speed at final visit (median 18 months). Secondary outcomes were handgrip strength at 1-year follow-up and yearly change in muscle mass. Results we included 267 participants from Switzerland and the Netherlands. Mean age was 77.5 years (range 65.1–97.1), 129 (48.3%) were women, and their mean baseline TSH was 6.36 mIU/l (standard deviation [SD] 1.9). At final visit, mean TSH was 3.8 mIU/l (SD 2.3) in the levothyroxine group and 5.1 mIU/l (SD 1.8, P < 0.05) in the placebo group. Compared to placebo, participants in the levothyroxine group had similar gait speed at final visit (adjusted between-group mean difference [MD] 0.01 m/s, 95% confidence interval [CI] −0.06 to 0.09), similar handgrip strength at one year (MD −1.22 kg, 95% CI −2.60 to 0.15) and similar yearly change in muscle mass (MD −0.15 m2, 95% CI −0.49 to 0.18). Conclusions in this ancillary analysis of two RCTs, treatment of subclinical hypothyroidism did not affect muscle function, strength and mass in individuals 65 years and older.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypothyroidismThyroid HormonesAgedAged, 80 and overFemaleHumansMaleMuscle, SkeletalThyrotropinThyroxine

Stichwörter der Autor:innen

levothyroxinemuscleolder peoplesarcopeniasubclinical hypothyroidism

Substanzen

Thyroid HormonesThyrotropinThyroxine

Autor:innen und Institutionen

  • Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
  • Population Health Laboratory, University of Fribourg, Fribourg, Switzerland.
  • Interdisciplinary Center for Bone Diseases, Service of Rheumatology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Service of Endocrinology, Diabetes, Nutrition and Therapeutic Education, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.
  • Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.

ORCID-Profile: Seraina Netzer, Elena Gonzalez Rodriguez, Simon Mooijaart

Förderung

  • Swiss National Science Foundation
  • ZonMw programme Evidence-based Medicine in Old age

Zitieren

APA

Netzer, S., Chocano-Bedoya, P., Feller, M., Janett-Pellegri, C., Wildisen, L., Büchi, A. E., Moutzouri, E., Gonzalez Rodriguez, E., Collet, T. H., Poortvliet, R. K. E., Mc Carthy, V. J. C., Aeberli, D., Aujesky, D., Westendorp, R., Quinn, T. J., Gussekloo, J., Kearney, P. M., Mooijaart, S., Bauer, D. C., & Rodondi, N. (2023). The effect of thyroid hormone therapy on muscle function, strength and mass in older adults with subclinical hypothyroidism—an ancillary study within two randomized placebo controlled trials. Age and Ageing, 52(1). https://doi.org/10.1093/ageing/afac326

Vancouver

Netzer S, Chocano-Bedoya P, Feller M, Janett-Pellegri C, Wildisen L, Büchi AE, et al. The effect of thyroid hormone therapy on muscle function, strength and mass in older adults with subclinical hypothyroidism—an ancillary study within two randomized placebo controlled trials. Age and Ageing. 2023;52(1). doi:10.1093/ageing/afac326

BibTeX
@article{Netzer2023,
  author = {Netzer, Seraina and Chocano-Bedoya, Patricia and Feller, Martin and Janett-Pellegri, Camilla and Wildisen, Lea and Büchi, Annina E and Moutzouri, Elisavet and Gonzalez Rodriguez, Elena and Collet, Tinh-Hai and Poortvliet, Rosalinde K E and Mc Carthy, Vera J C and Aeberli, Daniel and Aujesky, Drahomir and Westendorp, Rudi and Quinn, Terence J and Gussekloo, Jacobijn and Kearney, Patricia M and Mooijaart, Simon and Bauer, Douglas C and Rodondi, Nicolas},
  title = {The effect of thyroid hormone therapy on muscle function, strength and mass in older adults with subclinical hypothyroidism—an ancillary study within two randomized placebo controlled trials},
  journal = {Age and Ageing},
  year = {2023},
  volume = {52},
  number = {1},
  doi = {10.1093/ageing/afac326}
}
Kostenlos starten →